Long-term Fish Oil Lipid Emulsion Use in Children with Intestinal Failure-Associated Liver Disease

Release Date: August 1, 2017

Expiration Date (all CE credit must be claimed by the expiration date): August 31, 2018

Issue: 6

Volume: 41

Journal: Journal of Parenteral and Enteral Nutrition (JPEN)

Author (s):

Prathima Nandivada, MD, Resident, General Surgery, Beth Israel Deaconess Medical Center, Boston, MA

Gillian L. Fell, MD, Research Fellow, Pediatric Surgery, Boston Children’s Hospital, Boston, MA

Paul D. Mitchell, Senior Biostatistician, Clinical Research Center; Puder Research Lab, Boston Children’s Hospital, Boston, MA

Alexis K. Potemkin, RN, Clinical Research Nurse Coordinator, Department of Surgery, Children’s Hospital Boston, Boston, MA

Alison A. O’Loughlin, MEd, Clinical Research Specialist II, Department of Surgery, Children’s Hospital Boston, Boston, MA

Kathleen M. Gura, PharmD, BCNSP, FASHP, FPPAG, FASPEN, Clinical Pharmacist GI/Nutrition Team Leader, Surgical

Programs, Boston Children’s Hospital, Boston, MA

Mark Puder, MD, PhD, Professor, Surgery, Harvard Medical School; Senior Associate in Surgery, Department of Surgery, Boston Children’s Hospital, Boston, MA

Link to article: Link

Journal-based CE Activity Overall Goal:

The JPEN Editor, in concurrence with ASPEN’s Education and Professional Development Committee, selected this article to be offered for CE credit to fill an observed learning need in the arena of clinical nutrition and metabolism. This CE activity serves to promote the process of life-long learning for physicians, dietitians, pharmacists, and nurses by providing peer-reviewed journal articles that fully qualify for continuing education credits.

Goal and Target Audience:

This educational activity is directed toward clinical nutrition and metabolism professionals and others who wish to update their knowledge of clinical nutrition and metabolism. By participating in this educational activity, the reader may expect to:

• Acquire knowledge in the area of clinical nutrition and metabolism research

• Update or confirm your understanding of appropriate clinical nutrition and metabolism practices.

• Identify further learning needs as they relate to the subject matter.

Learning Objectives:

1. Recognize biochemical essential fatty acid deficiency.

2. Counsel patients with long term parenteral nutrition (PN) and fish oil lipid emulsion dependence on their expected growth curves.

3. Counsel patients with long term PN and fish oil lipid emulsion dependence on their risk of essential fatty acid deficiency.

Requirements for Successful Completion:
To obtain CE credit for this activity, attendees must read the journal article in its entirety, complete an online knowledge assessment for each article and achieve a score of 100%, and complete an online activity evaluation. All CE credit must be claimed prior to the expiration date.

Accreditation Statements/Continuing Education Credit:

Nurses, Pharmacists and Physicians

In support of improving patient care, The American Society for Parenteral and Enteral Nutrition (ASPEN) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity is for a maximum of 1 contact hour (0.1 CEU) per journal article and is a knowledge activity.

ASPEN designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credits ^TM per article. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ASPEN is approved by the California Board of Registered Nursing, Provider CEP 3970.

ACPE UAN: 0216-0000-17-058-H01-P. Knowledge activity.

Dietitians

ASPEN, Provider Number AM005, is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR level 2. Dietitians may post comments on this program on www.cdrnet.org.

Policies/Information:

Non-Commercialism: ASPEN subscribes to the ACCME Standards for Commercial Support. ASPEN does not provide programs that constitute advertisement or include promotional materials. ASPEN does not endorse any products.

Computer Requirements and Technical Support: Participants will need a computer with internet connection to access the online assessment and evaluation for each journal article. If the journal article is read electronically, then the ability to read a PDF document is also necessary. Users should enable pop-ups if attempting to read article electronically. For technical difficulties please contact Digitell Inc. Customer Support at: 1-800-679-3646

Office hours are between 9AM to 5PM ET, Monday through Friday

Privacy and Confidentiality: ASPEN respects the privacy of its members and website visitors. Companies that receive personal information from ASPEN in order to execute the business of ASPEN may use personal information only for that purpose.

Refund Policy: Refunds are not available.

Grievances: Grievances must be submitted in writing to Director of Education at ASPEN 8630 Fenton Street. Suite 412. Silver Spring, MD 20910.

Commercial Support and Sponsorship:
No commercial support or sponsorship has been received for this continuing education activity.

Commercial Relationships Disclosures and Conflicts of Interest (COI) of Authors and Editor-in-Chief and Associate Editors

Among the authors, the following have nothing to disclose: Prathima Nandivada, Gillian L. Fell, Paul D. Mitchell, Alexis K. Potemkin, and Alison A. O’Loughlin

Kathleen M. Gura has served as a member of the scientific advisory board for Pronova BASF and Sancillio & Company and received honorarium. Member of pharmaceutical advisory board for B Braun and received honorarium. Collaborator/consultant with Fresenius Kabi resulting in licensing agreement between Boston Children’s Hospital and Fresenius Kabi.

Mark Puder has served as an investigator - Fresenius Kabi resulting in licensing agreement between Boston Children’s Hospital and Fresenius Kabi. Patent holder with US Patents for the use of omegaven in the prevention and treatment of PNALD.

Among the JPEN Associate Editors, David August, Ronald Koretz, Ding-You Li, Jean-Charles Preiser, and Diana Mager have nothing to disclose.

JPEN Editor-in-Chief Kelly Tappenden has served in a speaking role for NPS Pharmaceuticals, Inc, Nutricia, and Abbott Nutrition and has received honoraria for those roles.

No conflicts related to disclosure information present and subsequently no need for resolution. Standard journal peer-review process also in place as another layer of review to ensure no conflicts to resolve.